# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-25-036833
Filing Date
2025-04-21
Accepted
2025-04-21 16:06:30
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm251075d3_ars.pdf | ARS | 14378531
| Complete submission text file | 0001104659-25-036833.txt |  | 19805086

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-15006 | Film No.: 25853185
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)